Literature DB >> 15750345

Transduced Tat-SOD fusion protein protects against ischemic brain injury.

Dae Won Kim1, Won Sik Eum, Sang Ho Jang, So Young Kim, Hee Soon Choi, Soo Hyun Choi, Jae Jin An, Sun Hwa Lee, Kil Soo Lee, Kyuhyung Han, Tae-Cheon Kang, Moo Ho Won, Jung Hoon Kang, Oh-Shin Kwon, Sung-Woo Cho, Tae Yoon Kim, Jinseu Park, Soo Young Choi.   

Abstract

Reactive oxygen species (ROS) are implicated in reperfusion injury after transient focal cerebral ischemia. The antioxidant enzyme, Cu,Zn-superoxide dismutase (SOD), is one of the major means by which cells counteract the deleterious effects of ROS after ischemia. Recently, we reported that when Tat-SOD fusion protein is transduced into pancreatic beta cells it protects the beta cells from destruction by relieving oxidative stress in ROS-implicated diabetes (Eum et al., 2004). In the present study, we investigated the protective effects of Tat-SOD fusion protein against neuronal cell death and ischemic insults. When Tat-SOD was added to the culture medium of neuronal cells, it rapidly entered the cells and protected them against paraquat-induced cell death. Immunohistochemical analysis revealed that Tat-SOD injected intraperitoneally (i.p.) into mice has access to various tissues including brain neurons. When i.p. injected into gerbils, Tat-SOD prevented neuronal cell death in the hippocampus in response to transient fore-brain ischemia. These results suggest that Tat-SOD provides a strategy for therapeutic delivery in various hu-man diseases, including stroke, related to this anti-oxidant enzyme or to ROS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750345

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  15 in total

1.  Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis.

Authors:  Nigar Fatma; E Kubo; M Sen; N Agarwal; W B Thoreson; C B Camras; D P Singh
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

Review 2.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  TAT-mediated protein transduction of Nogo extracellular peptide 1-40 and its biological activity.

Authors:  Qiang Wang; Xingchun Gou; Weilin Jin; Lize Xiong; Lichao Hou; Shaoyang Chen; Hui Zhang; Xiaoling Zhu; Lixian Xu
Journal:  Cell Mol Neurobiol       Date:  2008-08-29       Impact factor: 5.046

4.  Advances in stroke therapy.

Authors:  Hayder Jaffer; Viola B Morris; Desiree Stewart; Vinod Labhasetwar
Journal:  Drug Deliv Transl Res       Date:  2011-12-01       Impact factor: 4.617

5.  A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model.

Authors:  Piyush M Vyas; Wendy J Tomamichel; P Melanie Pride; Clifford M Babbey; Qiujuan Wang; Jennifer Mercier; Elizabeth M Martin; R Mark Payne
Journal:  Hum Mol Genet       Date:  2011-11-23       Impact factor: 6.150

6.  Crystallization and preliminary X-ray diffraction analysis of the SOD-TAT fusion protein.

Authors:  Jianru Pan; Kangjing Zhou; Guangjin Zheng; Shutao Liu; Pingfan Rao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-04-20

Review 7.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

Review 8.  Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke.

Authors:  Sheikh Arshad Saeed; Kaneez Fatima Shad; Taimur Saleem; Faisal Javed; Muhammad Umair Khan
Journal:  Exp Brain Res       Date:  2007-07-31       Impact factor: 1.972

9.  In vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probe.

Authors:  Youshi Fujita; Takahiro Kuchimaru; Tetsuya Kadonosono; Shotaro Tanaka; Yoshiki Hase; Hidekazu Tomimoto; Masahiro Hiraoka; Shinae Kizaka-Kondoh; Masafumi Ihara; Ryosuke Takahashi
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  Cell-penetrating superoxide dismutase attenuates oxidative stress-induced senescence by regulating the p53-p21(Cip1) pathway and restores osteoblastic differentiation in human dental pulp stem cells.

Authors:  Yoon Jung Choi; Jue Yeon Lee; Chong Pyoung Chung; Yoon Jeong Park
Journal:  Int J Nanomedicine       Date:  2012-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.